4.6 Article

Downregulation of Ubiquitin-Specific Protease 15 (USP15) Does Not Provide Therapeutic Benefit in Experimental Mesial Temporal Lobe Epilepsy

Journal

MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -

Publisher

SPRINGER
DOI: 10.1007/s12035-023-03692-2

Keywords

Neuroinflammation; TGF-beta; IFN-alpha/beta; NRF2; Microglia; Seizure; Kainate

Categories

Ask authors/readers for more resources

Structural epilepsies display complex immune activation signatures, but the specific neuroinflammatory pathways driving the pathology are unclear. Transcriptome studies in patients with mesial temporal lobe epilepsy (mTLE) identified dysregulation of transforming growth factor beta, interferon alpha/beta, and nuclear factor erythroid 2-related factor 2 pathways. However, in a mouse model, lack of Usp15 did not significantly affect severity of status epilepticus or the expression of inflammatory pathways.
Structural epilepsies display complex immune activation signatures. However, it is unclear which neuroinflammatory pathways drive pathobiology. Transcriptome studies of brain resections from mesial temporal lobe epilepsy (mTLE) patients revealed a dysregulation of transforming growth factor beta, interferon alpha/beta, and nuclear factor erythroid 2-related factor 2 pathways. Since these pathways are regulated by ubiquitin-specific proteases (USP), in particular USP15, we hypothesized that USP15 blockade may provide therapeutic relief in treatment-resistant epilepsies. For validation, transgenic mice which either constitutively or inducibly lack Usp15 gene expression underwent intrahippocampal kainate injections to induce mTLE. We show that the severity of status epilepticus is unaltered in mice constitutively lacking Usp15 compared to wild types. Cell death, reactive gliosis, and changes in the inflammatory transcriptome were pronounced at 4 days after kainate injection. However, these brain inflammation signatures did not differ between genotypes. Likewise, induced deletion of Usp15 in chronic epilepsy did not affect seizure generation, cell death, gliosis, or the transcriptome. Concordantly, siRNA-mediated knockdown of Usp15 in a microglial cell line did not impact inflammatory responses in the form of cytokine release. Our data show that a lack of USP15 is insufficient to modulate the expression of relevant neuroinflammatory pathways in an mTLE mouse model and do not support targeting USP15 as a therapeutic approach for pharmacoresistant epilepsy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available